BRCA2 and breast cancer: Breast tumors expressing none of these are called triple-negative breast cancers (TNBC), which comprise about 15 % of breast cancers overall, about 70 % of breast cancers in individuals harboring a germline BRCA1 mutation, and 20 % in BRCA2 mutation carriers [1–4].